全文获取类型
收费全文 | 1652篇 |
免费 | 88篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 27篇 |
妇产科学 | 11篇 |
基础医学 | 258篇 |
口腔科学 | 29篇 |
临床医学 | 112篇 |
内科学 | 402篇 |
皮肤病学 | 12篇 |
神经病学 | 115篇 |
特种医学 | 26篇 |
外科学 | 382篇 |
综合类 | 5篇 |
预防医学 | 37篇 |
眼科学 | 16篇 |
药学 | 152篇 |
中国医学 | 4篇 |
肿瘤学 | 148篇 |
出版年
2023年 | 17篇 |
2022年 | 13篇 |
2021年 | 37篇 |
2020年 | 23篇 |
2019年 | 36篇 |
2018年 | 37篇 |
2017年 | 19篇 |
2016年 | 26篇 |
2015年 | 28篇 |
2014年 | 37篇 |
2013年 | 56篇 |
2012年 | 74篇 |
2011年 | 80篇 |
2010年 | 43篇 |
2009年 | 36篇 |
2008年 | 75篇 |
2007年 | 86篇 |
2006年 | 95篇 |
2005年 | 70篇 |
2004年 | 70篇 |
2003年 | 70篇 |
2002年 | 66篇 |
2001年 | 58篇 |
2000年 | 47篇 |
1999年 | 47篇 |
1998年 | 22篇 |
1997年 | 22篇 |
1996年 | 24篇 |
1995年 | 17篇 |
1994年 | 14篇 |
1993年 | 14篇 |
1992年 | 46篇 |
1991年 | 25篇 |
1990年 | 35篇 |
1989年 | 26篇 |
1988年 | 26篇 |
1987年 | 41篇 |
1986年 | 24篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 18篇 |
1982年 | 11篇 |
1979年 | 11篇 |
1978年 | 9篇 |
1976年 | 7篇 |
1975年 | 10篇 |
1974年 | 11篇 |
1973年 | 10篇 |
1970年 | 10篇 |
1967年 | 9篇 |
排序方式: 共有1754条查询结果,搜索用时 15 毫秒
41.
Frequent loss of heterozygosity in two distinct regions,8p23.1 and 8p22, in hepatocellular carcinoma 总被引:1,自引:0,他引:1
Tomoe Lu Hiroshi Hano Keisuke Nagatsuma Satoru Chiba Masahiro Ikegami 《World journal of gastroenterology : WJG》2007,(7)
AIM: To identify the precise location of putative tumor suppressor genes (TSGs) on the short arm of chromo- some 8 in patients with hepatocellular carcinoma (HCC). METHODS: We used 16 microsatellite markers informative in Japanese patients, which were selected from 61 pub- lished markers, on 8p, to analyze the frequency of loss of heterozygosity (LOH) in each region in 33 cases (56 lesions) of HCC. RESULTS: The frequency of LOH at 8p23.2-21 with at least one marker was 63% (20/32) in the informative cases. More specifically, the frequency of LOH at 8p23.2, 8p23.1, 8p22, and 8p21 was 6%, 52%, 47%, and 13% in HCC cases. The LOH was significantly more frequent at 8p23.1 and 8p22 than the average (52% vs 22%, P = 0.0008; and 47% vs 22%, P = 0.004, respectively) or others sites, such as 8p23.2 (52% vs 6%, P = 0.003; 47% vs 22%, P = 0.004) and 8p21 (52% vs 13%, P = 0.001; 47% vs 13%, P = 0.005) in liver cancer on the basis of cases. Notably, LOH frequency was significantly higher at D8S277, D8S503, D8S1130, D8S552, D8S254 and D8S258 than at the other sites. However, no allelic loss was detected at any marker on 8p in the lesions of nontumor liver tissues. CONCLUSION: Deletion of 8p, especially the loss of 8p23.1-22, is an important event in the initiation or promotion of HCC. Our results should be useful in identi- fying critical genes that might lie at 8p23.1-22. 相似文献
42.
Akane Hara Tomohiro Watanabe Kosuke Minaga Tomoe Yoshikawa Ken Kamata Masatoshi Kudo 《World journal of gastroenterology : WJG》2021,27(19):2257-2269
Solitary organ autoimmune disorders, formerly known as autoimmune pancreatitis (AIP), autoimmune sialadenitis, and autoimmune sclerosing cholangitis, are now considered organ-specific manifestations of systemic immunoglobulin G4-related disease (IgG4-RD). AIP and IgG4-RD are characterized by elevated serum concentration of IgG4 antibody (Ab), accumulation of IgG4-expressing plasmacytes in the affected organs, and involvement of multiple organs. It is well established that enhanced IgG4 Ab responses are a hallmark of AIP and IgG4-RD for diagnosis and monitoring disease activity. However, a significant fraction of patients with AIP and IgG4-RD who develop chronic fibroinflammatory responses have normal serum concentrations of this IgG subtype. In addition, disease flare-up is sometimes seen even in the presence of normalized serum concentrations of IgG4 Ab after successful induction of remission by prednisolone. Therefore, it is necessary to identify new biomarkers based on the understanding of the pathophysiology of AIP and IgG4-RD. Recently, we found that activation of plasmacytoid dendritic cells producing both interferon-α (IFN-α) and interleukin-33 (IL-33) mediate murine AIP and human IgG4-RD. More importantly, we provided evidence that serum concentrations of IFN-α and IL-33 could be useful biomarkers for the diagnosis and monitoring of AIP and IgG4-RD activity after induction of remission in these autoimmune disorders. In this Frontier article, we have summarized and discussed biomarkers of AIP and IgG4-RD, including Igs, autoAbs, and cytokines to provide useful information not only for clinicians but also for researchers. 相似文献
43.
H Hirose K Ohmori Y Nakaoka K Kitamura T Muramatsu Y Namiki F Nagasaka M Koga M Shimamura Y Sezai 《Nihon Kokyūki Gakkai zasshi》1998,36(12):1027-1031
We report on a 31-year-old man with a mediastinal neurilemmoma originating in the right phrenic nerve. The patient was admitted because of abnormal chest X-ray shadows observed during a routine checkup. A preoperative diagnosis of bronchial cyst in the mediastinum was made. The tumor was resected by video-assisted thoracic surgery. It was 3 x 4 x 3 cm in size, weighted 15 g, and originated in the right phrenic nerve. The histopathologic diagnosis was mediastinal neurilemmoma. Only 14 cases have been reported in the Japanese literature. 相似文献
44.
45.
46.
Masahiko?TaniguchiEmail author Tsuyoshi?Shimamura Satoru?Todo Hiroyuki?Furukawa 《Surgery today》2015,45(6):663-671
In living-donor liver transplantation with a left lobe graft, which can reduce the burden on the donor compared to right lobe graft, the main problem is small-for-size (SFS) syndrome. SFS syndrome is a multifactorial disease that includes aspects related to the graft size, graft quality, recipient factors and even technical issues. The main pathophysiology of SFS syndrome is the sinusoidal microcirculatory disturbance induced by shear stress, which is caused by excessive portal inflow into the smaller graft. The donor age, the presence of steatosis of the graft and a poor recipient status are all risk factors for SFS syndrome. To resolve SFS syndrome, portal inflow modulation, splenectomy, splenic artery modulation and outflow modulation have been developed. It is important to establish strict criteria for managing SFS syndrome. Using pharmacological interventions and/or therapeutic approaches that promote liver regeneration could increase the adequate outcomes in SFS liver transplantation. Left lobe liver transplantation could be adopted in Western countries to help resolve the organ shortage. 相似文献
47.
48.
Yo Ueda Hikaru Tomoe Hiroyuki Takahashi Yuko Takahashi Hiroyuki Yamashita Hiroshi Kaneko 《Modern rheumatology / the Japan Rheumatism Association》2016,26(3):445-449
We report a case of interstitial cystitis (IC) associated with primary Sjögren's syndrome (SS) successfully controlled with combination therapy of tacrolimus and a corticosteroid. In 2011, a 69-year-old female, who had been diagnosed with primary SS 23 years ago, developed IC and was successfully treated with tacrolimus and prednisolone combination therapy. The mechanism of IC, including the involved autoimmunity, has not been elucidated. Clinical observation studies suggest a potential association between SS and IC. However, IC is currently thought to be underdiagnosed in patients with SS as well as in the general population. Based on our case and others reported previously, IC associated with SS responds well to immunosuppressive therapy. In particular, a combination of a calcineurin inhibitor (tacrolimus or cyclosporine) with a corticosteroid seems to be highly effective. The possibility of IC in patients with SS complaining of lower urinary tract symptoms without features of infection or other identifiable causes should be given attention. 相似文献
49.
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? 总被引:4,自引:0,他引:4
Inamori M Togawa J Iwasaki T Ozawa Y Kikuchi T Muramatsu K Chiguchi G Matsumoto S Kawamura H Abe Y Kirikoshi H Kobayashi N Shimamura T Kubota K Sakaguchi T Saito S Ueno N Nakajima A 《Journal of gastroenterology》2005,40(5):453-458
Background Medication for the relief of heartburn should have the rapid onset of action required for on-demand use. We studied the inhibition of gastric acid secretion by lafutidine and rabeprazole, given in single doses to fasting and postprandial subjects.Methods A total of 22 healthy male, Helicobacter pylori-negative volunteers participated in this randomized, two-way crossover study. They were randomly assigned to receive a single oral dose of 10mg lafutidine or 20mg rabeprazole after fasting overnight (12 subjects, fasting study) or after eating a test meal (noodles, 364kcal; protein, 10.1g; fat, 16g; carbohydrates, 44.9g; NaCl, 1.1g; 10 subjects, postprandial study). Intragastric pH was monitored continuously for 6h after treatment. The other drug was given after a washout period of at least 7 days, and intragastric pH was similarly monitored.Results In the fasting study, lafutidine sustained pH at >3 and >4 during the second, third, fourth, fifth, and sixth hours of the study for significantly longer than rabeprazole. During the first 6h after treatment, lafutidine sustained pH at more than 2, 3, 3.5, 4, 5, 6, and 7 longer than rabeprazole. In the postprandial study, lafutidine sustained pH >3 and >4 for longer periods than rabeprazole during the third, fourth, fifth, and sixth hours of the study. During the first 6h after treatment, lafutidine sustained pH at more than 2, 3, 3.5, 4, 5, 6, and 7 longer than rabeprazole.Conclusions Lafutidine 10mg produces a prompter rise in intragastric pH than rabeprazole 20mg in fasting and postprandial Helicobacter pylori-negative male subjects. 相似文献
50.
Masatsugu Ohara Goki Suda Megumi Kimura Osamu Maehara Tomoe Shimazaki Taku Shigesawa Kazuharu Suzuki Akihisa Nakamura Naoki Kawagishi Masato Nakai Takuya Sho Mitsuteru Natsuizaka Kenichi Morikawa Koji Ogawa Tomoe Kobayashi Minoru Uebayashi Ryo Takagi Isao Yokota Tsuyoshi Shimamura Naoya Sakamoto 《Hepatology research》2020,50(6):715-725